Literature DB >> 16534686

MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice.

C Hoebler1, E Gaudier, P De Coppet, M Rival, C Cherbut.   

Abstract

Colonic mucosal protection is provided by mucous gel, mainly composed of secreted (Muc2) and membrane-bound (Muc1, Muc3, Muc4) mucins. Our aim was to determine the expression profile of secreted and membrane-bound mucins in experimental dextran sulfate sodium (DSS)-induced colitis. Acute colitis was induced in Balb/C mice by oral administration of 1.0% DSS (5 days) and chronic colitis was maintained by subsequent 0.15% DSS treatment (28 days). Clinical symptoms (mortality, weight gain), stool scores, and MPO activity confirmed the inflammatory state in the two phases of colitis. Muc2 gene expression was not modified by colitis, whereas Muc3 gene expression was increased (x2) only in the cecum and the distal colon of mice after acute colitis. Muc1 and Muc4 mRNA levels were more significantly increased in the cecum (x8-10) than in colonic segments (x4) after acute colitis. TFF3 involved in mucosal repair was up-regulated during colitis induction. These results indicate that Muc and TFF3 genes are regulated early in inflammation and suggest that their mRNA levels could be used as early markers of inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534686     DOI: 10.1007/s10620-006-3142-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

Review 1.  [MUC genes: a superfamily of genes? Towards a functional classification of human apomucins].

Authors:  N Porchet; M P Buisine; J L Desseyn; N Moniaux; S Nollet; P Degand; P Pigny; I Van Seuningen; A Laine; J P Aubert
Journal:  J Soc Biol       Date:  1999

2.  Involvement of the MAP kinase ERK2 in MUC1 mucin signaling.

Authors:  D Meerzaman; P S Shapiro; K C Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

3.  Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice.

Authors:  M Mähler; I J Bristol; J P Sundberg; G A Churchill; E H Birkenmeier; C O Elson; E H Leiter
Journal:  Genomics       Date:  1999-01-15       Impact factor: 5.736

4.  Mucin depletion in inflammatory bowel disease.

Authors:  D A McCormick; L W Horton; A S Mee
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

5.  Quantitative analysis of MUC2 synthesis in ulcerative colitis.

Authors:  K M Tytgat; J W van der Wal; A W Einerhand; H A Büller; J Dekker
Journal:  Biochem Biophys Res Commun       Date:  1996-07-16       Impact factor: 3.575

6.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.

Authors:  H Kindon; C Pothoulakis; L Thim; K Lynch-Devaney; D K Podolsky
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis.

Authors:  Noëlle M Moreau; Lucile J Martin; Claire S Toquet; Christian L Laboisse; Patrick G Nguyen; Brigitte S Siliart; Henri J Dumon; Martine M J Champ
Journal:  Br J Nutr       Date:  2003-07       Impact factor: 3.718

8.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

9.  Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats.

Authors:  M Faure; D Moënnoz; F Montigon; C Mettraux; S Mercier; E J Schiffrin; C Obled; D Breuillé; J Boza
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 10.  Cell signaling through membrane mucins.

Authors:  Kermit L Carraway; Victoria P Ramsauer; Bushra Haq; Coralie A Carothers Carraway
Journal:  Bioessays       Date:  2003-01       Impact factor: 4.345

View more
  22 in total

1.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

2.  Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.

Authors:  Tingting Ju; Yasmeen Shoblak; Yanhua Gao; Kaiyuan Yang; Janelle Fouhse; B Brett Finlay; Yee Wing So; Paul Stothard; Benjamin P Willing
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

3.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Seema Singh; Sumit Arora; Bin Wang; William E Grizzle; Ajay P Singh
Journal:  Carcinogenesis       Date:  2011-10-07       Impact factor: 4.944

4.  Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases.

Authors:  Subhankar Chakraborty; Benjamin J Swanson; Neelima Bonthu; Surinder K Batra
Journal:  J Clin Pathol       Date:  2010-07       Impact factor: 3.411

5.  Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.

Authors:  Nadine Rohwer; Sandra Jumpertz; Merve Erdem; Antje Egners; Klaudia T Warzecha; Athanassios Fragoulis; Anja A Kühl; Rafael Kramann; Sabine Neuss; Ines Rudolph; Tobias Endermann; Christin Zasada; Ivayla Apostolova; Marco Gerling; Stefan Kempa; Russell Hughes; Claire E Lewis; Winfried Brenner; Maciej B Malinowski; Martin Stockmann; Lutz Schomburg; William Faller; Owen J Sansom; Frank Tacke; Markus Morkel; Thorsten Cramer
Journal:  Oncogene       Date:  2019-05-01       Impact factor: 9.867

6.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

7.  Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice.

Authors:  Géraldine Leforestier; Anne Blais; François Blachier; Agnès Marsset-Baglieri; Anne-Marie Davila-Gay; Emmanuel Perrin; Daniel Tomé
Journal:  Eur J Nutr       Date:  2009-07-04       Impact factor: 5.614

8.  Glucocorticoid availability in colonic inflammation of rat.

Authors:  P Ergang; P Leden; J Bryndová; S Zbánková; I Miksík; M Kment; J Pácha
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

9.  Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.

Authors:  S Das; S Rachagani; Y Sheinin; L M Smith; C B Gurumurthy; H K Roy; S K Batra
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

10.  CaM kinase II in colonic smooth muscle contributes to dysmotility in murine DSS-colitis.

Authors:  S Qureshi; J Song; H-T Lee; S D Koh; G W Hennig; B A Perrino
Journal:  Neurogastroenterol Motil       Date:  2009-09-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.